Scientific ReportsEcologyPeer-reviewed journal article
Major microbiota transitions across liver disease progression are mediated by key taxa linking host environments and microbial communities
Kenta SuzukiiD, Tomonori KamiyaiD, Hideki FujiiiD, Sotaro TakanoiD, Yoshimi Yukawa‐MutoiD, Norifumi KawadaiD, Shinji FukudaiD, Hiroshi MasuyaiD, Naoko OhtaniiD
Abstract
The gut microbiome plays a critical role in chronic liver disease, yet quantitative methods that integrate microbial community structure with clinical indices remain limited. Here, we applied an energy landscape analysis (ELA)-based framework to characterize transitions in gut microbiota along a clinical gradient of liver disease severity, as measured by the FibroScan-AST (FAST) score. The analysis revealed characteristic community states corresponding to low, intermediate, and high FAST scores, indicating that liver disease progression is associated with structured transitions in microbial community organization rather than simple changes in overall diversity. To further dissect community-level organization, we developed the community shaping index (CSI), which quantifies how strongly individual taxa are associated with specific community structures. Integrating CSI with species-environment association parameters identified key taxa with distinct ecological roles, including unclassified Subdoligranulum taxon, an unclassified Ruminococcus gnavus group taxon, and Streptococcus salivarius, that link host environmental conditions with community composition. Exploratory causal discovery suggested that Streptococcus salivarius and the unclassified Subdoligranulum may play distinct, potentially active roles in linking liver health with gut microbial organization, but with contrasting associations: S. salivarius was linked to disease-related liver deterioration and dysbiotic states, whereas the unclassified Subdoligranulum was associated with healthier liver function and coherent community organization. Overall, this ecologically grounded framework provides a unified and mechanistic foundation for analyzing microbiome structure and disease-associated transitions.
- organism: human
- assay: metagenomics
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: clustering
- research focus: differential expression
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 34%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Human liver microbiota modeling strategy at the early onset of fibrosis
R. Burcelin, C. Champion, … J.-M. Loubes·bioRxiv·Dec 10, 2020
- Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice
- Microbial oral-gut translocation in advanced chronic liver disease is linked to exacerbation of intestinal barrier dysfunction and hepatic fibrosis
Shen Jin, Aurélie Cenier, … Melanie Schirmer·bioRxiv·Sep 23, 2025
- Liver microbiome composition associates with histological severity and PNPLA3 genotype in metabolic dysfunction-associated steatotic liver disease
María Florencia Mascardi, R. Taussig, … Julieta Trinks·bioRxiv·Jul 1, 2026
- Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesis
J. Wyss, T. Raselli, … B. Misselwitz·bioRxiv·Dec 2, 2022
- Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse model
N. Fei, S. Miyoshi, … V. A. Leone·bioRxiv·Jan 9, 2023